期刊文献+

Sinomenine reduces iNOS expressionvia inhibiting the T-bet IFN-γ pathway in experimental autoimmune encephalomyelitis in rats 被引量:11

下载PDF
导出
摘要 Sinomenine is a bioactive alkaloid isolated from the Chinese medicinal plant Sinomenium acutum. It is widely used as an immunosuppressive drug for treating rheumatic and arthritic diseases. In our previous studies, we found that sinomenine reduced cellular infiltration within the spinal cord and alleviated experimental autoimmune encephalomyelitis (EAE) in rats. In this study, we further investigated the mechanisms of sinomenine treatment in EAE rats. In EAE rats, treatment with sinomenine exerted an anti-inducible NO synthase (anti-iNOS) effect, which is related to the reductions of Thl cytokine interferon-y (IFN-7) and its transcription factor, T-bet, in spinal cords. Moreover, sinomenine treatment of splenocytes stimulated with anti-CD3 antibody and recombinant rat in- terleukin 12 reduced the expression of T-bet and IFN-y in vitro and also reduced the capability of supernatants of splenocyte culture to induce iNOS expression by primary astrocytes. However, sinomenine had no direct inhibito- ry effect on iNOS produced by astrocytes cultured with IFN-y and tumor necrosis factor α in vitro. In conclusion, the anti-iNOS effect of sinomenine on EAE is mediated via the suppression of T-bet/IFN-y pathway. Sinomenine is a bioactive alkaloid isolated from the Chinese medicinal plant Sinomenium acutum. It is widely used as an immunosuppressive drug for treating rheumatic and arthritic diseases. In our previous studies, we found that sinomenine reduced cellular infiltration within the spinal cord and alleviated experimental autoimmune encephalomyelitis (EAE) in rats. In this study, we further investigated the mechanisms of sinomenine treatment in EAE rats. In EAE rats, treatment with sinomenine exerted an anti-inducible NO synthase (anti-iNOS) effect, which is related to the reductions of Thl cytokine interferon-y (IFN-7) and its transcription factor, T-bet, in spinal cords. Moreover, sinomenine treatment of splenocytes stimulated with anti-CD3 antibody and recombinant rat in- terleukin 12 reduced the expression of T-bet and IFN-y in vitro and also reduced the capability of supernatants of splenocyte culture to induce iNOS expression by primary astrocytes. However, sinomenine had no direct inhibito- ry effect on iNOS produced by astrocytes cultured with IFN-y and tumor necrosis factor α in vitro. In conclusion, the anti-iNOS effect of sinomenine on EAE is mediated via the suppression of T-bet/IFN-y pathway.
出处 《The Journal of Biomedical Research》 CAS 2012年第6期448-455,共8页 生物医学研究杂志(英文版)
基金 supported by Science Fund of the Health Department of Jiangsu Province (No. H200504)
  • 相关文献

参考文献28

  • 1Buck D, Hemmer B. Treatment of multiple sclerosis: current concepts and future perspectives. J NeuroI2011; 258: 1747-62.
  • 2Sospedra M, Martin R. Immunology of multiple sclero?sis. Annu Rev Immunol2005; 23: 683-747.
  • 3Gold R, Linington C, Lassmann H. Understanding patho?genesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain 2006; 129: 1953-71.
  • 4Frischer JM, Bramow S, Dal-Bianco A, Lucchinetti CF, Rauschka H, Schmidbauer M, et al. The relation between inflammation and neurodegeneration in multiple sclero?sis brains. Brain 2009; 132: 1175-89.
  • 5Dutta R, Trapp BD. Pathogenesis of axonal and neuronal damage in multiple sclerosis. Neurology 2007; 68: 22- 3l.
  • 6Saha RN, Pahan K. Signals for the induction of nitric ox?ide synthase in astrocytes. Neurochem Int 2006; 49: 154- 63.
  • 7Teixeira SA, Castro GM, Papes F, Martins ML, Rogerio F, Langone F, et al. Expression and activity of nitric oxide synthase isoforms in rat brain during the develop?ment of experimental allergic encephalomyelitis. Brain Res Mol Brain Res 2002; 99: 17-25.
  • 8Bosnjak-Pasic M, Vidrih B, Miskov S, Demarin V. Treat?ment of multiple sclerosis. Acta Clin Croat 2009; 48: 349-53.
  • 9Liu L, Buchner E, Beitze D, Schmidt-Weber CB, Kaever V, Emmrich F, et al. Amelioration of rat experimental arthritides by treatment with the alkaloid sinomenine. Int J Immunopharmacol1996; 18: 529-43.
  • 10Zeng Y, Gu B, Ji X, Ding X, Song C, Wu F. Sinomenine, an antirheumatic alkaloid, ameliorates clinical signs of disease in the Lewis rat model of acute experimental au?toimmune encephalolmyelitis. BioI Pharm Bull 2007; 30: 1438-44.

同被引文献133

引证文献11

二级引证文献107

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部